How does the FDA approach performance evaluation compared to IVDR?

The FDA requires analytical and clinical validation data under 21 CFR Part 809 and relevant guidance documents, generally submitted through a 510(k), De Novo, or PMA pathway, whereas IVDR requires a Performance Evaluation Report following Annex XIII for CE marking.